PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2
Expression of the coding RNA PCAT-1 is associated with cisplatin resistance in gastric cancer, and suppressing PCAT-1 can re-sensitize cancer cells to treatment, a new study suggests.
Read Source